ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research

Merimepodib is shown to decrease viral production of COVID-19 coronavirus more than remdesivir at clinically meaningful drug concentrations in pre-clinical testing.   Article highlights recent work done in laboratory studies of COVID-19 with merimepodib at the Galveston National Laboratory at The University of Texas Medical Branch     Westport, CT – April 23, 2020 – […]

Orphan Drug Act Fueling $200 Billion Dollar Market

Palm Beach, FL – April 23, 2020 – The Orphan Drug Designation program provides orphan status to drugs and biologics which are defined as those intended for the treatment, prevention or diagnosis of a rare disease or condition, which is one that affects less than 200,000 persons in the US or meets cost recovery provisions […]

The Most Critical Metal In The 5G Revolution

FN Media Group Presents Market Commentary   London – April 23, 2020 – While the pandemic tanks oil and gas, decimating demand, and even precious metals aren’t feeling the safe-haven love they’re used to, critical minerals have become the holy grail, and one, in particular, could become the post-pandemic tech gold.   Mentioned in today’s […]